JAMA Network Open is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
There is a lot of talk off #IDSky about the @jamanetworkopen.com article about increased mortality in Cefepime.
I highly recommend the editorial:
-Difference is small (<1%)
-Most studies before 2010
-Dosing/Breakpoints changes since trials
-ACORN shows real 🌎safety
